Home QIAGEN

QIAGEN

In operation
Post-IPO Round
Technology provider of molecular testing solutions and R&D, producer of molecular diagnostic products
Basic
Enterprise Profile

Basic Information

QIAGEN N.V. provides technologies and products for pre-analytical sample preparation and linked molecular analysis solutions through its subsidiaries. The company also offers diagnostic kits, tests, and analytical methods for human and veterinary molecular diagnostics. Its sample preparation technologies enable the extraction, isolation, and purification of DNA, RNA, and proteins from a variety of biological samples. Meanwhile, QIAGEN is committed to developing comprehensive solutions covering the entire process from sample preparation to data interpretation, integrating sample handling, molecular diagnostic assays, and bioinformatics technologies into complete workflows to interpret molecular diagnostic data and generate clinically meaningful reports.
QIAGEN N.V.
Manchester,England,United Kingdom
more than 500 people
January 01, 1986
--

Enterprise Profile

Industrial Sector
Storage Database Scientific Research and Experimental Development Services Medical Consumables Manufacturing # Diagnostic Manufacturing
Technology
POCT Molecular Diagnostics Biotechnology Genetic Testing
Concept
Infectious Diseases Department Laboratory Diagnosis Lung Cancer Lymphoma HIV Hepatitis
Application Scenarios
Novel Coronavirus Medical Devices Medical Device Consumables AI + Medical Devices Companion Diagnostics